RankingsPricing
  1. US-listed companies
  2. Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc.NVOS

Market cap
$4.43M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Aug 31,
2017		Aug 31,
2018		Aug 31,
2019		Aug 31,
2020		Aug 31,
2021		Aug 31,
2022
Cash and cash equivalents-6,2933,4231,83114,12354,3502675,7052282
Accounts receivable, net------111211
Inventory, net----------339,385879,033
Other receivables, current portion------372,024393,821300,994302,664814,1571
Prepaid expenses and other current assets------252,536161,838250,398191,723218,376571,335
Total current assets18,75616,998345,0081,83114,12356,0804344116
Property and equipment, net7,05617,53812,7117,011--302,951400,321410,188353,66066
Intangible assets, net--------22273219
Right-of-use assets, net--------3333
Other receivables, net of current portion-------57,3521287,775692,738-
Goodwill------399,400604,113623,081636,94298
TOTAL ASSETS25,81234,536357,71922,59227,87369,8306532356241
Accounts payable116,290118,098146,14382,55013,12019,658211883,77312
Accrued expenses------341,657383,998205,784194,70811
Accrued interest (including amounts to related parties)14,95520,68424,24142,595--403,119156,121248,582346,264366,280454,189
Government loans and notes payable, current portion---------83,2924-
Convertible notes payable, net of discount of $2,851,0488,31596,76710,356--------9
Contingent liability-----------534,595
Due to related parties------21920,083528,213478,920478,897
Finance lease liability, current portion----------23,1848,890
Operating lease liability, current portion--------508,305563,793530,797582,088
Total current liabilities141,089241,561557,747340,66413,12019,6584333814
Debentures, related parties-----------946,250
Government loans and notes payable, net of current portion-----------161,460
Finance lease liability, net of current portion----------16,21712,076
Operating lease liability, net of current portion--------3222
Deferred tax liability-----------1
TOTAL LIABILITIES2-----105761819
Common stock; $0.001 par value; 499,000,000 shares authorized; 31,180,603 and 26,610,144 shares issued and outstanding at August 31, 2022 and August 31, 2021, respectively56,503-----201,837207,882223,691234,66226,61031,181
Additional paid-in capital14171821222231036455566
Common stock to be issued (4,149,633 and 3,622,199 shares at August 31, 2022 and August 31, 2021)-----------9
Other comprehensive income---49,827--1111991,077560,836
Accumulated deficit----19,452,612-22,223,326-22,388,213-9,091,977-11,199,989-11,591,973-16,507,127-20,969,274-53,818,489
Total Novo Integrated Sciences, Inc. stockholders’ equity-2,328,111-797,356-947,867-625,67014,75350,172-4,267,653201,39126304422
Noncontrolling interest-------20,537-28,621-39,632-49,859-60,261-257,588
Total stockholders’ equity-------4,288,190172,77026304422
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY25,81234,536357,71922,59227,87369,8306532356241